Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification
about
Sp100 interacts with ETS-1 and stimulates its transcriptional activityThe histone deacetylase 9 gene encodes multiple protein isoformsDifferential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expressionNoncovalent interaction between Ubc9 and SUMO promotes SUMO chain formationMediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expressionThe SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylasePIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodiesAn acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activityThe RanBP2 SUMO E3 ligase is neither HECT- nor RING-typeNoncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia proteinCharacterisation of the SUMO-like domains of Schizosaccharomyces pombe Rad60A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defenceKaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivationThe forkhead transcription factor Foxl2 is sumoylated in both human and mouse: sumoylation affects its stability, localization, and activity.Identification of a novel post-translational modification in Plasmodium falciparum: protein sumoylation in different cellular compartmentsInteractions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9.Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot.The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system.SUMO: of branched proteins and nuclear bodies.Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis.SUMO conjugation attenuates the activity of the gypsy chromatin insulator.Versatile protein tag, SUMO: its enzymology and biological function.Ligand binding reduces SUMOylation of the peroxisome proliferator-activated receptor γ (PPARγ) activation function 1 (AF1) domainNuclear domain 10 of the viral aspect.Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathyTP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHVSp100A promotes chromatin decondensation at a cytomegalovirus-promoter-regulated transcription siteDifferential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradationInterplay between Herpesvirus Infection and Host Defense by PML Nuclear BodiesSP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis.Host cell restriction factors that limit transcription and replication of human papillomavirus.Sp100 isoform-specific regulation of human adenovirus 5 gene expression.The Human CMV IE1 Protein: An Offender of PML Nuclear Bodies.Sumoylation of the transcriptional intermediary factor 1beta (TIF1beta), the Co-repressor of the KRAB Multifinger proteins, is required for its transcriptional activity and is modulated by the KRAB domain.The adenovirus E4 ORF3 protein binds and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha.SUMOylation of the polyglutamine repeat protein, ataxin-1, is dependent on a functional nuclear localization signal.Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway.Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways.
P2860
Q24292513-ABC71FAD-0C47-4421-8C09-8D593CD35BDDQ24294872-DF399ACB-FAD4-4FF4-B0EF-351CD8E476BAQ24298241-3BE42A9F-A542-46B1-9699-D807FD5388E9Q24305202-2FCE4D7E-ED80-44A3-BB54-4F0D7141C6F6Q24336304-AB6C9424-3733-47CC-B63F-A1203DD664AEQ24337028-421793C3-AEB4-42B5-BFAB-2460E6763011Q24534918-9150D971-86B0-415D-8248-4B65FF3F64FAQ24599898-B533910E-97D4-4E07-B9E5-2E276AA2B5D8Q28117824-AB37CB6C-4051-4957-873E-5DB757380023Q28118953-D2C2EB0A-ECEC-41AD-B2E0-EDC776F6E007Q28295561-31B68A8C-2FCF-4EDC-9A8F-AA23E29514BCQ28475600-973BE874-5E79-4E3B-A7B0-5C5A6577DD8DQ28477120-D0C25BF0-CD7A-4EF5-AE62-288535BE95CDQ28535568-F0CABDF7-10E6-4C06-9BD2-C39930AA6CC4Q29871426-AD529EEE-7B38-47A0-83A2-43F8C526648CQ30046052-BE84E673-8932-448C-A4F6-F43658F23D8CQ33237313-CB398E43-B601-40D8-988D-1859C6BE6A4BQ34101415-CB50AACC-29B4-4F27-AC74-763E243D75E7Q34152334-0F9B7574-FACD-4263-B9FF-8F14B39CA149Q34435551-E136C41A-5ECE-4A96-B0A7-A64726BD68D7Q34525800-FAC216AE-C8BE-4658-A0EB-D0F646810686Q34590443-72949BF2-F425-48AA-BA14-61684F28378BQ34638636-432312A9-F9AB-458A-B8BC-BD854470D217Q34796273-63E96624-6D86-4820-9053-4953AB80B96FQ35047491-8E48685B-2C84-46FB-9E1F-F8A2FFB67483Q35276352-27CCBBE8-7417-4877-810E-0EB13A96D939Q35368917-BDD780A6-5FB0-4E7B-9A91-B3ECDDDF4792Q35755464-68D3E3B5-331B-464A-A19C-E482F25275B4Q36803209-C9D8C249-DABD-40B2-9CA1-87A1077FC255Q37192189-7D5CD612-D837-4D01-9036-9745A563A3C3Q37945188-BA48B6AD-2F80-457C-AF6B-CD3B97C683F2Q38837130-7562BE20-92B8-491D-9063-4888ED66EA49Q39013547-B3A3AE16-BE05-49CF-A64C-63AAA7CEB8CAQ39016075-51F1A0F6-FBAF-46EA-86BE-15BCA09083CFQ39320346-35345476-7413-42AD-826D-19C0D0219280Q40171341-198BF651-120A-425B-867A-D8BE166F354AQ40173431-2811FE14-AA82-4240-98A6-E3279F139177Q40436432-274D5111-2E95-40E2-A87F-0A2BC352990DQ40666794-A5360F23-0E4E-4550-A6C4-5A72894BA804Q40890409-9DF7FB16-6DBA-421B-8314-BA46C5EE52F6
P2860
Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Common properties of nuclear b ...... tor: role of SUMO modification
@ast
Common properties of nuclear b ...... tor: role of SUMO modification
@en
Common properties of nuclear b ...... tor: role of SUMO modification
@en-gb
Common properties of nuclear b ...... tor: role of SUMO modification
@nl
type
label
Common properties of nuclear b ...... tor: role of SUMO modification
@ast
Common properties of nuclear b ...... tor: role of SUMO modification
@en
Common properties of nuclear b ...... tor: role of SUMO modification
@en-gb
Common properties of nuclear b ...... tor: role of SUMO modification
@nl
prefLabel
Common properties of nuclear b ...... tor: role of SUMO modification
@ast
Common properties of nuclear b ...... tor: role of SUMO modification
@en
Common properties of nuclear b ...... tor: role of SUMO modification
@en-gb
Common properties of nuclear b ...... tor: role of SUMO modification
@nl
P2093
P2860
P1476
Common properties of nuclear b ...... tor: role of SUMO modification
@en
P2093
P2860
P304
P356
10.1128/MCB.21.10.3314-3324.2001
P407
P577
2001-05-01T00:00:00Z